Cell therapy for left ventricular dysfunction: an overview for cardiac clinicians

Area of Science:

• Cardiovascular regeneration
• Cell-based therapies
• Regenerative medicine

Background:

• Heart failure presents a significant global health burden with high morbidity and costs.
• Developing effective cell therapies is crucial for cardiovascular regeneration.
• Numerous cell types are under investigation for cardiac repair, complicating the field.

Purpose of the Study:

• To provide an overview of cell types being explored for cardiac cell therapy.
• To summarize the current landscape of clinical trials and research in cardiac regeneration.
• To highlight the translational progress and future potential of cell-based cardiac repair.

Main Methods:

• Review of existing literature on cell types for cardiac therapy.
• Analysis of cell populations from extra-cardiac and cardiac sources.
• Examination of ongoing and completed clinical trials and preclinical studies.

Main Results:

• Key cell types include skeletal myoblasts, bone marrow mononuclear cells, mesenchymal stem cells, and various cardiac stem cell populations.
• Bone marrow mononuclear cells are the most studied, with ongoing large clinical trials.
• Early phase trials are investigating mesenchymal stem cells and cardiac stem cells, while embryonic stem cell therapies are in large animal models.

Conclusions:

• Significant translational progress has been made in cardiac cell therapy research.
• Multiple cell products and protocols for cardiac repair are anticipated in the near future.
• Continued investigation into diverse cell sources is driving innovation in cardiovascular regeneration.